BioWorld

Feb. 28, 2008

View Archived Issues

FDA Pledges Renewed Focus to Boost Post-Market Safety

More than 100 years after the creation of the FDA, the agency said it now will apply the same standards it uses in its premarket drug reviews to manage its post-marketing safety process. (BioWorld Today) Read More

Regeneron Gets FDA's OK for Arcalyst in CAPS

Read More

New Connections of Clotting to Inflammation in Sepsis, MS

Read More

NewCo News: Profectus Seeks a Bio Niche Hitting HIV from all Angles

Read More

Biogen, Elan Nicked on Reports of Tysabri-Linked Liver Injuries

Read More

RegeneRx Secures $5M for Wound Healing Trials

Read More

Receptor Logic Finds Partner to Develop T-Cell Mimics

Read More

Other News To Note

Read More

Earnings Roundup

Read More

Clinic Roundup

Read More